GGrantIndex
← Search

EVALUATION OF THE USE OF POXVIRUS VACCINES TO STIMULATE P53 SPECIFIC IMMUNITY

$4,131M01FY2005RRNIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →